Clinical Trial Update: Pre-operative Immunotherapy in Stage II-III Urothelial Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pre-operative immunotherapy for stage II-III urothelial carcinoma; status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Urothelial Carcinoma | Phase 1 | Status: COMPLETED